Exposure to Obinutuzumab Does Not Affect Outcomes of SARS-CoV-2 Infection in Vaccinated Patients with Newly Diagnosed Advanced-Stage Follicular Lymphoma.

A. Pinto, M. Caltagirone, M. Battista, G. C. Gazzoli, C. Patti,E. Pennese,S. De Lorenzo, V. Pavone, M. Merli, A. Chiarenza, A. G. Gorgone, F. Piazza, B. Puccini, A. Noto,L. Arcaini, R. De Filippi, P. L. Zinzani,A. J. M. Ferreri, M. Ladetto, S. Ferrari, G. Gritti

BRITISH JOURNAL OF HAEMATOLOGY（2024）

Cited 0|Views5

No score

Key words

follicular lymphoma,maintenance,obinutuzumab,SARS-CoV-2 infection,vaccination

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined